Linkage disequilibrium analysis of chromosome 12q14-15 in multiple sclerosis: Delineation of a 118-kb interval around interferon-γ (IFNG) that is involved in male versus female differential susceptibility

Genes and Immunity

Volumn 3, Issue 8, 2002, Pages 470-476

  Goris, A ^a   Heggarty, S ^b   Marrosu, M G ^c   Graham, C ^b   Billiau, A ^a   Vandenbroeck, K ^b  

^a REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

^b QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^c UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

Association; Chromosome 12q; Gender; Interferon ; Linkage disequilibrium; Multiple sclerosis

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 22; INTERLEUKIN 26;

ARTICLE; CHROMOSOME 12Q; CONTROLLED STUDY; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENE LOCATION; GENE LOCUS; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; HAPLOTYPE; HEREDITY; HUMAN; LINKAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; MARKER GENE; MICROSATELLITE MARKER; MULTIPLE SCLEROSIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SEX DIFFERENCE; ADOLESCENT; ADULT; CHROMOSOME 12; COMPARATIVE STUDY; GENETIC PREDISPOSITION; GENETICS; SEXUAL DEVELOPMENT;

ADOLESCENT; ADULT; CHROMOSOMES, HUMAN, PAIR 12; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTERFERON TYPE II; LINKAGE DISEQUILIBRIUM; MALE; MULTIPLE SCLEROSIS; SEX CHARACTERISTICS;

EID: 0037553853     PISSN: 14664879     EISSN: 14765470     Source Type: Journal    
DOI: 10.1038/sj.gene.6363913     Document Type: Article

References (47)

1. Svejgaard A. HLA controlled susceptibility to multiple sclerosis-a survey. In: Hommes OR, Clanet M, Wekerle H (ed). Genes and Viruses in Multiple Sclerosis. Elsevier: Amsterdam, 2001, pp 25-35.
2. Chataway J, Feakes R, Coraddu F et al. The genetics of multiple sclerosis: principles, background and updated results of the United Kingdom systematic genome screen. Brain 1998; 121: 1869-1887.
3. Duquette P, Pleines J, Girard M, Charest L, Senecal-Quevillon M, Masse C. The increased susceptibility of women to multiple sclerosis. Can J Neurol Sci 1992; 19: 466-471.
4. Billiau A. Interferon-γ in autoimmunity. Cytokine Growth Factor Rev 1996; 7: 25-34.
5. Beck J, Rondot P, Catinot L, Falcoff E, Kirchner H, Wietzerbin J. Increased production of interferon gamma and tumor necrosis factor precedes clinical manifestation in multiple sclerosis: do cytokines trigger off exacerbations? Acta Neurol Scand 1988; 78: 318-323.
6. Lu CZ, Jensen MA, Arnason BG. Interferon gamma- and interleukin-4- secreting cells in multiple sclerosis. J Neuroimmunol 1993; 46: 123-128.
7. Dettke M, Scheldt P, Prange H, Kirchner H. Correlation between interferon production and clinical disease activity in patients with multiple sclerosis. J Clin Immunol 1997; 17: 293-300.
8. Panitch HS, Hirsch RL, Haley AS, Johnson KP. Exacerbations of multiple sclerosis in patients treated with gamma interferon. Lancet 1987; 1: 893-895.
9. The Multiple Sclerosis Genetics Group. A complete genomic screen for multiple sclerosis underscores a role for the major histocompatibility complex. Nat Genet 1996; 13: 469-471.
10. Bureau JF, Montagutelli X, BiH F, Lefebvre S, Guénet J-L, Brahic M. Mapping loci influencing the persistence of Theiler's virus in the murine central nervous system. Nat Genet 1993; 5: 87-91.
11. Vandenbroeck K, Opdenakker G, Goris A, Murru R, Billiau A, Marrosu MG. Interferon-γ gene polymorphism-associated risk for multiple sclerosis in Sardinia. Ann Neurol 1998; 44: 841-842.
12. Goris A, Epplen C, Fiten P et al. Analysis of an IFN-γ gene (IFNG) polymorphism in multiple sclerosis in Europe: effect of population structure on association with disease. J Interferon Cytokine Res 1999; 19: 1037-1046.
13. Weinshenker BG, Kantarci OH, Goris A et al. Polymorphisms of interferon gamma (IFNG) contribute to gender-based differential susceptibility to MS. Am J Hum Genet 2001; 69 (Suppl 1): 576 (Abstr. 2320).
14. Marrosu MG, Murru MR, Costa G et al. Multiple sclerosis in Sardinia is associated and in linkage disequilibrium with HLA-DR3 and -DR4 alleles. Am J Hum Genet 1997; 61: 454-457.
15. Dai Y, Masterman T, Huang WX et al. Analysis of an interferon-γ gene dinucleotide-repeat polymorphism in Nordic multiple sclerosis patients. Multiple Sclerosis 2001; 7: 157-163.
16. Jorde LB, Watkins WS, Kere J, Nyman D, Eriksson AW. Gene mapping in isolated populations: new roles for old friends? Hum Hered 2000; 50: 57-65.
17. Eaves IA, Merriman TR, Barber RA et al. The genetically isolated populations of Finland and Sardinia may not be a panacea for linkage disequilibrium mapping of common disease genes. Nat Genet 2000; 25: 320-323.
18. Fickenscher H, Hör S, Küpers H, Knappe A, Wittman S, Sticht H. The interleukin-10 family of cytokines. Trends Immunol 2002; 23: 89-96.
19. Knappe A, Hör S, Wittmann S, Fickenscher H. Induction of a novel cellular homolog of interleukin-10, AK155, by transformation of T lymphocytes with herpesvirus saimiri. J Virol 2000; 74: 3881-3887.
20. Dumoutier L, Van Roost E, Colau D, Renauld JC. Human interleukin-10- related T cell-derived inducible factor: molecular cloning and functional characterization as an hepatocyte-stimulating factor. Proc Natl Acad Sci USA 2000; 97: 10144-10149.
21. Xie MH, Aggarwal S, Ho W-H et al. Interleukin (IL)-22, a novel human cytokine that signals through the interferon receptor-related proteins CRF2-4 and IL-22R. J Biol Chem 2000; 275: 31335-31339.
22. Snyder LC, Trusko SP, Freeman N, Eshleman JR, Fakharzadeh SS, George DL. A gene amplified in a transformed mouse cell line undergoes complex transcriptional processing and encodes a nuclear protein. J Biol Chem 1988; 263: 17150-17158.
23. Spielman RS, McGinnis RE, Ewens WJ. Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet 1993; 52: 506-516.
24. Herr M, Dudbridge F, Zavattari P et al. Evaluation of fine mapping strategies for a multifactorial disease locus: systematic linkage and association analysis of IDDM1 in the HLA region on chromosome 6p21. Hum Mol Genet 2000; 9: 1291-1301.
25. Goris A, Marrosu M, Vandenbroeck K. Novel polymorphisms in the IL-10 related AK155 gene (chromosome 12q15). Genes Immun 2001; 2: 284-286.
26. Giedraitis VE, He B, Hillert J. Mutation screening of the interferon-gamma gene as a candidate for multiple sclerosis. Eur J Immunogenet 1999; 26: 257-259.
27. Iwasaki H, Ota N, Nakajima T et al. Five novel single-nucleotide polymorphisms of human interferon gamma identified by sequencing the entire gene. J Hum Genet 2001; 46: 32-34.
28. Pravica V, Perrey C, Stevens A, Lee J-H, Hutchinson IV. A single nucleotide polymorphism in the first intron of the human IFN-γ gene: absolute correlation with a polymorphic CA microsatellite marker of high IFN-γ production. Hum Immunol 2000; 61: 863-866.
29. Wu S, Muhleman D, Comings DE. G5644A polymorphism in the interferon-gamma (IFNG) gene. Psychiatr Genet 1998; 8: 57.
30. Bream JH, Carrington M, O'Toole S et al. Polymorphisms of the human IFNG gene noncoding regions. Immunogenetics 2000; 51: 50-58.
31. Huygen K, Palfliet K. Strain variation in interferon γ production of BCG-sensitized mice challenged with PPD. 2. Importance of one major autosomal locus and additional sexual influences. Cell Immunol 1984; 85: 75-81.
32. McFarland HI, Bigley NJ. Sex-dependent, early cytokine production by NK-like spleen cells following infection with the D variant of encephalomyocarditis virus (EMCV-D). Viral Immunol 1989; 2: 205-214.
33. Ishikawa R, Bigley N. Sex hormone modulation of interferon (IFN) alpha/beta and gamma production by mouse spleen cell subsets following picornavirus infection. Viral Immunol 1990; 3: 225-236.
34. Fox HS, Bond BL, Parslow TG. Estrogen regulates the IFN-γ promotor. J Immunol 1991; 146: 4362-4367.
35. Verthelyi D, Klinman DM. Sex hormone levels correlate with the activity of cytokine-secreting cells in vivo. Immunology 2000; 100: 384-390.
36. Bihl F, Brahic M, Bureau JF. Two loci, Tmevp2 and Tmevp3, located on the telomeric region of chromosome 10, control the persistence of Theiler's virus in the central nervous system of mice. Genetics 1999; 152: 385-392.
37. Vigneau S, Levillayer F, Crespeau H et al. Homology between a 173-kb region from mouse chromosome 10, telomeric to the Ifng locus, and human chromosome 12q15. Genomics 2001; 78: 206-213.
38. John S, Myerscough A, Marlow A et al. Linkage of cytokine genes to rheumatoid arthritis. Evidence of genetic heterogeneity. Ann Rheum Dis 1998; 57: 361-365.
39. Ollier WER. Role of interferon-γ gene in rheumatoid arthritits? Lancet 2000; 356: 784.
40. Lio D, Scola L, Crivello A et al. Allele frequencies of +874T-a single nucleotide polymorphism at the first intron of interferon-γ gene in a group of Italian centenarians. Exp Gerontol 2002; 37: 315-319.
41. Poser CM, Paty DW, Scheinberg L et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1993; 13: 227-231.
42. Knapp M. A note on power approximations for the transmission/ disequilibrium test. Am J Hum Genet 1999; 64: 1177-1185.
43. Falk CT, Rubinstein P. Haplotype relative risks: an easy reliable way to construct a proper control sample for risk calculations. Ann Hum Genet 1987; 51: 227-233.
44. Sasieni PD. From genotypes to genes: doubling the sample size. Biometrics 1997; 53: 1253-1261.
45. Agresti A. On logit confidence intervals for the odds ratio with small samples. Biometrics 1999; 55: 597-602.
46. Schneider S, Roessli D, Excoffier L. Arlequin: a Software for Population Genetics Data Analysis. Version 2.000. Genetics and Biometry Laboratory, University of Geneva: Geneva, 2000, http://anthropologie.unige.ch/arlequin.
47. Hedrick PW. Gametic disequilibrium measures: proceed with caution. Genetics 1987; 117: 331-341.